Submissions from 2020
LGBTQIA plus health care: Faculty development and medical student education, L. Block, N. Ha, R. R. Pleak, and D. W. Rosenthal
Allergy and Lung Injury Among Rescue Workers Exposed to the World Trade Center Disaster Assessed 17 Years After Exposure to Ground Zero, D. L. Caruana, P. H. Huang, J. C. Li, K. Cheslack-Postava, and A. M. Szema
Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology, I. K. Chinn, A. Y. Chan, K. Chen, J. Chou, M. J. Dorsey, J. Hajjar, A. M. Jongco, M. D. Keller, L. J. Kobrynski, J. E. Walter, and +14 additional authors
Submissions from 2019
Secondary Hypogammaglobulinemia An Increasingly Recognized Complication of Treatment with Immunomodulators and After Solid Organ Transplantation, B. Kaplan and V. R. Bonagura
Submissions from 2018
Noninfectious manifestations and complications of chronic granulomatous disease, S. E. Henrickson, A. M. Jongco, K. F. Thomsen, E. K. Garabedian, and I. P. Thomsen
Considerations in the diagnosis of chronic granulomatous disease, J. E. Yu, A. E. Azar, H. J. Chong, A. M. Jongco, and B. T. Prince
Submissions from 2015
A Note from the Editor-in-Chief, Deputy Editor, and Managing Editor, V. R. Bonagura, J. L. Casanova, and D. W. Rosenthal
Predictors of Long-Term Renal Outcome in Lupus Nephritis Trials Lessons Learned from the Euro-Lupus Nephritis Cohort, M. Dall'Era, M. G. Cisternas, D. E. Smilek, L. Straub, F. A. Houssiau, R. Cervera, B. H. Rovin, and M. Mackay
Reply to: Nasal endoscopy to characterize sinonasal disease, A. E. Dixon, M. Castro, R. I. Cohen, L. B. Gerald, J. T. Holbrook, C. G. Irvin, S. Mohapatra, S. P. Peters, S. Rayapudi, R. A. Wise, and +1 additional author
Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort, B. Parker, M. B. Urowitz, D. D. Gladman, M. Lunt, R. Donn, S. C. Bae, J. Sanchez-Guerrero, C. Aranow, M. Mackay, I. N. Bruce, and +30 additional authors
A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial, F. Tamirou, B. R. Lauwerys, M. Dall'Era, M. Mackay, B. Rovin, R. Cervera, F. A. Houssiau, D. Abramowicz, L. de Bruxelles, R. Westhovens, and +35 additional authors
Submissions from 2014
Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study, A. Askanase, M. Byron, L. Keyes-Elstein, P. Cagnoli, J. McCune, B. Diamond, D. Daikh, A. Davidson, M. Mackay, D. Wofsy, and +24 additional authors
Treatment of Lupus Nephritis With Abatacept, A. D. Askanase, M. Byron, L. L. Keyes-Elstein, P. C. Cagnoli, W. J. McCune, W. W. Chatham, A. Davidson, B. Diamond, M. Mackay, R. Winchester, and +24 additional authors